10/31/14 TFX 114.12 Teleflex Inc $TFX Hit a 52 wee
Post# of 57
Posted On: 11/02/2014 3:18:24 AM
10/31/14 TFX 114.12 Teleflex Inc $TFX Hit a 52 week high of 114.51 Closing the day 10/31/14 at 114.12 +1.25 +1.11% With a day low of 113.25 and a total volume of 276,100.
TFX Recent Posts: http://investorshangout.com/Teleflex-Inc-TFX-52821/
TFX Teleflex Inc Recent Headline News
Australia Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG
M2 - Fri Oct 31, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mm6kv7/australia) has announced the addition of the "Australia Surgical Sutures Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Key Topics Covered: 1 List of Tables 2 Introduction 3 Surgical Sutures Market, Australia 4 Overview of Key Companies in Australia, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned: - Johnson & Johnson - Covidien plc - B. Braun Melsungen AG - Dynek Pty. Ltd. - Boston Scientific Corporation - Teleflex Incorporated - Sutures India Private Limited For more information visit http://www.researchandmarkets.com/research/mm6kv7/australia
BSX: 13.28 (+0.10), JNJ: 107.78 (+0.74), TFX: 114.12 (+1.25)
Downgrade Alert for Teleflex (TFX)
Comtex SmarTrend(R) - Thu Oct 30, 8:00AM CDT
Teleflex (NYSE:TFX) was downgraded from Overweight to Equal Weight at Stephens today. The stock closed yesterday at $112.23 on volume of 289,000 shares, above average daily volume of 268,000. Teleflex has overhead space with shares priced $112.23, or 5.7% below the average consensus analyst price target of $119.00. The stock should find initial support at its 50-day moving average (MA) of $108.28 and further support at its 200-day MA of $104.48.
TFX: 114.12 (+1.25)
Teleflex to Introduce Innovative Portfolio at EMS World Expo 2014
Business Wire - Thu Oct 30, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, is committed to connecting emergency clinicians to technology in a way that improves clinical practice and patient outcomes. Teleflex will showcase its broad portfolio of Arrow(R) and LMA(R) branded products -- including the Arrow(R) EZ-IO(R) Intraosseous Vascular Access System and the LMA Supreme(R) Next Generation EMS Supraglottic Airway -- at the EMS World Expo 2014, November 11-13, in Nashville, Tennessee.
TFX: 114.12 (+1.25)
Teleflex beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
WAYNE, Pa. (AP) _ Teleflex Inc. (TFX) on Wednesday reported profit of $54.8 million in its third quarter.
TFX: 114.12 (+1.25)
Teleflex Announces Quarterly Dividend
Business Wire - Wed Oct 29, 6:30AM CDT
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2014 to shareholders of record at the close of business on November 14, 2014.
TFX: 114.12 (+1.25)
Teleflex Reports Third Quarter 2014 Results
Business Wire - Wed Oct 29, 6:00AM CDT
--Third Quarter GAAP Diluted EPS of $1.18, up 12.4% over the prior year period; Adjusted Diluted EPS of $1.57 up 18.0%
TFX: 114.12 (+1.25)
Teleflex Awarded U.S. Army Grant to Develop Anti-Biofilm Orthopedic Device
Business Wire - Tue Oct 28, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that it has been awarded a $2.1 million research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, MD. The award will support research and development of a surface-modified tibial intramedullary nail that combines the Semprus Sustain(TM) technology with antimicrobial technology. Up to an additional $2.46 million in funding for the project may be provided under the award, at the U.S. Army's discretion.
TFX: 114.12 (+1.25)
Teleflex Announces ARROW(R) EZ-IO(R) Vascular Access System Reaches 3 Million Needles Sold Milestone
Business Wire - Mon Oct 27, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that the ARROW(R) EZ-IO(R) Vascular Access System has reached a new growth milestone by surpassing 3 million needles sold globally in early September 2014.
TFX: 114.12 (+1.25)
4 Stocks Spiking on Unusual Volume
at The Street - Tue Oct 21, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
VSI: 46.93 (-0.54), VTL: 17.26 (-0.78), BBRY: 10.50 (+0.02), TFX: 114.12 (+1.25)
China Surgical Sutures Market Outlook 2020: Key Players are Johnson & Johnson, Covidien plc and B. Braun Melsungen AG
M2 - Tue Oct 21, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnx974/china_surgical) has announced the addition of the "China Surgical Sutures Market Outlook to 2020" report to their offering. "China Surgical Sutures Market Outlook to 2020", provides key market data on the China Surgical Sutures market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Automated Suturing Devices (Reusable and Disposable Automated Suturing Devices) and Sutures (Absorbable and .Non-Absorbable Sutures). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Surgical Sutures market. - Global corporate-level profiles of key companies operating within the China Surgical Sutures. - Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Surgical Sutures Market, China 4 Overview of Key Companies in China, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned - Johnson & Johnson - Covidien plc - B. Braun Melsungen AG - Ningbo Hengwei Import & Export Co., Ltd - Sutures India Private Limited - Teleflex Incorporated - Heze Healthicon Medical Instruments For more information visit http://www.researchandmarkets.com/research/wn...a_surgical
JNJ: 107.78 (+0.74), TFX: 114.12 (+1.25)
United States Wound Closure Devices Market Outlook 2020: Key Players are Johnson & Johnson, Baxter International & Pfizer
M2 - Mon Oct 20, 8:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mkcdwn/united_states) has announced the addition of the "United States Wound Closure Devices Market Outlook to 2020" report to their offering. "United States Wound Closure Devices Market Outlook to 2020", provides key market data on the United States Wound Closure Devices Therapy market. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Wound Closure Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments: - Hemostats (Thrombin Based Combination Oxidized Regenerated Cellulose Based Gelatin Based and Collagen Based Hemostats) - Tissue Adhesives (Cyanoacrylate Based and Other Cross-linkable Polymer Based Tissue Adhesives) - Tissue Sealants (Synthetic Tissue Sealants and Non-Synthetic Tissue Sealants (Fibrin Based Tissue Sealants (Fibrin Based Tissue Sealants in Liquid Form and in Patch Form) - Collagen Based Tissue Sealants and Protein Based Tissue Sealants)) - Ligating Clips (Titanium and Polymer Ligating Clips) - Surgical Stapling Devices (Powered Surgical Stapling Devices (Reusable Powered and Disposable Powered Surgical Stapling Devices) - Manual Surgical Stapling Devices (Reusable Manual and Disposable Manual Surgical Stapling Devices)) - Surgical Adhesion Barriers (Membrane and Gel Adhesion Barriers) and Wound Closure Strips. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Wound Closure Devices market. - Global corporate-level profiles of key companies operating within the United States Wound Closure Devices. - Key players covered include Johnson & Johnson, Baxter International Inc. and Pfizer Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Wound Closure Devices Market, United States 4 Overview of Key Companies in United States, Wound Closure Devices Market 5 Wound Closure Devices Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned - Johnson & Johnson - Covidien plc - Baxter International Inc. - Pfizer Inc. - 3M Health Care Ltd - Genzyme Corporation - Teleflex Incorporated - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/mk...ted_states
JNJ: 107.78 (+0.74), BAX: 70.14 (+0.08), PFE: 29.95 (+0.11), TFX: 114.12 (+1.25)
Teleflex Partnership with ASA Raises Funds for Lifebox Foundation at ANESTHESIOLOGY(TM) 2014 Annual Meeting
Business Wire - Mon Oct 20, 8:03AM CDT
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced that they have donated $20,000 to the Lifebox Foundation. The donation was the result of a Lifebox Challenge hosted by Teleflex during the ANESTHESIOLOGY(TM) 2014 Annual Meeting in October. Teleflex donated $20 for every meeting attendee who participated in the Lifebox photo challenge.
TFX: 114.12 (+1.25)
Teleflex to Present at 44th Annual Meeting of the International Continence Society (ICS)
Business Wire - Fri Oct 17, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase its comprehensive bladder management product lines and incontinence care products at the 44th Annual Meeting of the International Continence Society (ICS) in Rio de Janeiro, Brazil on October 20-24, 2014.
TFX: 114.12 (+1.25)
Teleflex Announces Third Quarter 2014 Earnings Conference Call Information
Business Wire - Wed Oct 15, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the third quarter 2014 will be released before market open on Wednesday, October 29, 2014. An investor conference call will be held at 8:00 a.m. (ET) on Wednesday, October 29, 2014. The call can be accessed through a live audio webcast on the company's website, www.teleflex.com. An audio replay of the call will also be available on the website from October 29, 2014 at 12:00 p.m. (ET) to November 5, 2014 at 11:59 p.m. (ET) by calling 888-286-8010 (U.S./Canada) or 617-801-6888 (International), Passcode: 14097601.
TFX: 114.12 (+1.25)
Teleflex Unites its World-Class Arrow(R), Hudson RCI(R), LMA(R) and Rusch(R) Brands at ANESTHESIOLOGY(TM) 2014
Business Wire - Thu Oct 09, 8:01AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will be featuring medical technology designed to improve patient outcomes and reduce healthcare costs at the ANESTHESIOLOGY(TM) 2014 annual meeting, October 11-15th in New Orleans.
TFX: 114.12 (+1.25)
After Yesterday's Rally of 2.25% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Oct 06, 5:28PM CDT
Teleflex (NYSE:TFX) traded in a range yesterday that spanned from a low of $107.05 to a high of $109.42. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $107.19 on volume of 332,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TFX: 114.12 (+1.25)
Teleflex Incorporated Announces Worldwide Voluntary Recall of Hudson RCI(R) Pediatric Anesthesia Breathing Circuits
Business Wire - Fri Oct 03, 8:00AM CDT
Teleflex Incorporated announced today that the U.S. Food and Drug Administration (FDA) has classified the voluntary medical device recall of Hudson RCI(R) Pediatric Anesthesia Breathing Circuits as a Class 1 recall. FDA defines Class I recalls as, "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death."
TFX: 114.12 (+1.25)
Teleflex Up on Catheter Expansion Plans in Czech Republic - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 2:00PM CDT
Teleflex (TFX) rolled out its restructuring plan in April this year in order to reduce costs and streamline manufacturing operations.
ATEC: 1.52 (-0.05), TFX: 114.12 (+1.25), ERB: 3.08 (unch), HOLX: 26.19 (+0.27)
Global Home Healthcare Market 2014 - 2020: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices & Mobility Assist Devices and Medical Supplies
M2 - Tue Sep 30, 5:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/thxb6j/global_home) has announced the addition of the "Global Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global home healthcare market is estimated to be USD 176,107.9 million in 2013 and is expected to reach USD 303,605.9 million by 2020, growing at a CAGR of 8.1% from 2014 to 2020 Increasing sedentary lifestyle and aging population globally would surge the demand of home healthcare devices and services market. However, accuracy and limited geographic presence of service providers are some of the factors that restrict the growth of this market. For example, home healthcare service providers like The Linde Group and Gentiva Health Services, Inc. has limited market geographic presence in economies like Asia-Pacific, Russia and Latin America. The market of global home healthcare market is categorized as device types and services. Home healthcare devices market is segmented as diagnostics and monitoring home healthcare devices, therapeutics home healthcare devices, mobility assist devices and medical supplies. The market for diagnostics and monitoring devices segment accounted for the largest share owing to rising prevalence of chronic diseases coupled with increasing healthcare awareness. However, therapeutics home healthcare devices segment is expected to grow at the highest CAGR of over 10% from 2014 to 2020. Introduction of advanced and easy to use therapeutics home healthcare devices will help this segment to record highest CAGR. Services segment in the global home healthcare market accounted for the largest share in 2013. This dominance was majorly due to the presence of large number of home healthcare service providers and strong acquisition strategies of these healthcare service providers. The Global home healthcare market is segmented as follows: Global Home Healthcare Market, by Device Types Diagnostics and Monitoring Home Devices - Blood Glucose Monitors - Blood Pressure Monitors - Heart Rate Monitors - Temperature Monitors - Sleep Apnea Monitors - Coagulation Monitors - Pregnancy Test Kits - Pulse Oximeters - Pedometers Therapeutics Home Healthcare Devices - Insulin Delivery Devices - Nebulizers - Ventilator and CPAP Devices - IV Equipments - Dialysis Equipment Home Mobility Assist Devices - Wheelchairs - Cranes and Crutches - Other Home Mobility Assist Devices Medical Supplies Global Home Healthcare Market, by Services - Rehabilitation Services - Telehealth and Telemedicine Services - Infusion Therapy Services - Respiratory Therapy Services - Unskilled Home Healthcare Services Companies Mentioned - 3M Healthcare - Abbott Laboratories - Bayer AG - Becton, Dickinson and Company - Cardinal Health - F. Hoffmann-La Roche Ltd. - GE Healthcare - Gentiva Health Services, Inc. - Invacare Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Omron Healthcare, Inc. - Philips Healthcare - Praxair Technologies, Inc. - ResMed, Inc. - Sunrise Medical LLC - Teleflex Incorporated - The Linde Group For more information visit http://www.researchandmarkets.com/research/th...lobal_home
JNJ: 107.78 (+0.74), ABT: 43.59 (+0.10), MDT: 68.16 (+0.73), IVC: 15.71 (+0.01), RMD: 52.22 (+0.11), TFX: 114.12 (+1.25), GTIV: 19.70 (+0.06)
Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
ZMH: 111.24 (+1.96), WST: 51.25 (+1.07), BDX: 128.70 (+1.18), PHG: 27.94 (+0.46), MDT: 68.16 (+0.73), CAH: 78.48 (+0.29), KMB: 114.27 (+0.65), EW: 120.92 (+0.64), WMGIZ: 4.39 (-0.06), MSA: 57.47 (+1.91), COO: 163.90 (+0.24), BSX: 13.28 (+0.10), ISRG: 495.80 (+5.80), JNJ: 107.78 (+0.74), PLL: 91.42 (+0.50), IVC: 15.71 (+0.01), STE: 61.80 (+0.96), BAX: 70.14 (+0.08), STJ: 64.17 (-0.11), TFX: 114.12 (+1.25), SYK: 87.53 (+0.49)
TFX Recent Posts: http://investorshangout.com/Teleflex-Inc-TFX-52821/
TFX Teleflex Inc Recent Headline News
Australia Surgical Sutures Market Outlook to 2020: Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG
M2 - Fri Oct 31, 5:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mm6kv7/australia) has announced the addition of the "Australia Surgical Sutures Market Outlook to 2020" report to their offering. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Key Topics Covered: 1 List of Tables 2 Introduction 3 Surgical Sutures Market, Australia 4 Overview of Key Companies in Australia, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned: - Johnson & Johnson - Covidien plc - B. Braun Melsungen AG - Dynek Pty. Ltd. - Boston Scientific Corporation - Teleflex Incorporated - Sutures India Private Limited For more information visit http://www.researchandmarkets.com/research/mm6kv7/australia
BSX: 13.28 (+0.10), JNJ: 107.78 (+0.74), TFX: 114.12 (+1.25)
Downgrade Alert for Teleflex (TFX)
Comtex SmarTrend(R) - Thu Oct 30, 8:00AM CDT
Teleflex (NYSE:TFX) was downgraded from Overweight to Equal Weight at Stephens today. The stock closed yesterday at $112.23 on volume of 289,000 shares, above average daily volume of 268,000. Teleflex has overhead space with shares priced $112.23, or 5.7% below the average consensus analyst price target of $119.00. The stock should find initial support at its 50-day moving average (MA) of $108.28 and further support at its 200-day MA of $104.48.
TFX: 114.12 (+1.25)
Teleflex to Introduce Innovative Portfolio at EMS World Expo 2014
Business Wire - Thu Oct 30, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, is committed to connecting emergency clinicians to technology in a way that improves clinical practice and patient outcomes. Teleflex will showcase its broad portfolio of Arrow(R) and LMA(R) branded products -- including the Arrow(R) EZ-IO(R) Intraosseous Vascular Access System and the LMA Supreme(R) Next Generation EMS Supraglottic Airway -- at the EMS World Expo 2014, November 11-13, in Nashville, Tennessee.
TFX: 114.12 (+1.25)
Teleflex beats Street 3Q forecasts
Automated Insights - Wed Oct 29, 9:07AM CDT
WAYNE, Pa. (AP) _ Teleflex Inc. (TFX) on Wednesday reported profit of $54.8 million in its third quarter.
TFX: 114.12 (+1.25)
Teleflex Announces Quarterly Dividend
Business Wire - Wed Oct 29, 6:30AM CDT
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2014 to shareholders of record at the close of business on November 14, 2014.
TFX: 114.12 (+1.25)
Teleflex Reports Third Quarter 2014 Results
Business Wire - Wed Oct 29, 6:00AM CDT
--Third Quarter GAAP Diluted EPS of $1.18, up 12.4% over the prior year period; Adjusted Diluted EPS of $1.57 up 18.0%
TFX: 114.12 (+1.25)
Teleflex Awarded U.S. Army Grant to Develop Anti-Biofilm Orthopedic Device
Business Wire - Tue Oct 28, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that it has been awarded a $2.1 million research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, MD. The award will support research and development of a surface-modified tibial intramedullary nail that combines the Semprus Sustain(TM) technology with antimicrobial technology. Up to an additional $2.46 million in funding for the project may be provided under the award, at the U.S. Army's discretion.
TFX: 114.12 (+1.25)
Teleflex Announces ARROW(R) EZ-IO(R) Vascular Access System Reaches 3 Million Needles Sold Milestone
Business Wire - Mon Oct 27, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced that the ARROW(R) EZ-IO(R) Vascular Access System has reached a new growth milestone by surpassing 3 million needles sold globally in early September 2014.
TFX: 114.12 (+1.25)
4 Stocks Spiking on Unusual Volume
at The Street - Tue Oct 21, 6:00AM CDT
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
VSI: 46.93 (-0.54), VTL: 17.26 (-0.78), BBRY: 10.50 (+0.02), TFX: 114.12 (+1.25)
China Surgical Sutures Market Outlook 2020: Key Players are Johnson & Johnson, Covidien plc and B. Braun Melsungen AG
M2 - Tue Oct 21, 5:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/wnx974/china_surgical) has announced the addition of the "China Surgical Sutures Market Outlook to 2020" report to their offering. "China Surgical Sutures Market Outlook to 2020", provides key market data on the China Surgical Sutures market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Automated Suturing Devices (Reusable and Disposable Automated Suturing Devices) and Sutures (Absorbable and .Non-Absorbable Sutures). The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Sutures market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Surgical Sutures market. - Global corporate-level profiles of key companies operating within the China Surgical Sutures. - Key players covered include Johnson & Johnson, Covidien plc and B. Braun Melsungen AG. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Surgical Sutures Market, China 4 Overview of Key Companies in China, Surgical Sutures Market 5 Surgical Sutures Market Pipeline Products 6 Appendix Companies Mentioned - Johnson & Johnson - Covidien plc - B. Braun Melsungen AG - Ningbo Hengwei Import & Export Co., Ltd - Sutures India Private Limited - Teleflex Incorporated - Heze Healthicon Medical Instruments For more information visit http://www.researchandmarkets.com/research/wn...a_surgical
JNJ: 107.78 (+0.74), TFX: 114.12 (+1.25)
United States Wound Closure Devices Market Outlook 2020: Key Players are Johnson & Johnson, Baxter International & Pfizer
M2 - Mon Oct 20, 8:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mkcdwn/united_states) has announced the addition of the "United States Wound Closure Devices Market Outlook to 2020" report to their offering. "United States Wound Closure Devices Market Outlook to 2020", provides key market data on the United States Wound Closure Devices Therapy market. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Wound Closure Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments: - Hemostats (Thrombin Based Combination Oxidized Regenerated Cellulose Based Gelatin Based and Collagen Based Hemostats) - Tissue Adhesives (Cyanoacrylate Based and Other Cross-linkable Polymer Based Tissue Adhesives) - Tissue Sealants (Synthetic Tissue Sealants and Non-Synthetic Tissue Sealants (Fibrin Based Tissue Sealants (Fibrin Based Tissue Sealants in Liquid Form and in Patch Form) - Collagen Based Tissue Sealants and Protein Based Tissue Sealants)) - Ligating Clips (Titanium and Polymer Ligating Clips) - Surgical Stapling Devices (Powered Surgical Stapling Devices (Reusable Powered and Disposable Powered Surgical Stapling Devices) - Manual Surgical Stapling Devices (Reusable Manual and Disposable Manual Surgical Stapling Devices)) - Surgical Adhesion Barriers (Membrane and Gel Adhesion Barriers) and Wound Closure Strips. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Wound Closure Devices market. - Global corporate-level profiles of key companies operating within the United States Wound Closure Devices. - Key players covered include Johnson & Johnson, Baxter International Inc. and Pfizer Inc. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Wound Closure Devices Market, United States 4 Overview of Key Companies in United States, Wound Closure Devices Market 5 Wound Closure Devices Market Pipeline Products 6 Financial Deals Landscape 7 Recent Developments 8 Appendix Companies Mentioned - Johnson & Johnson - Covidien plc - Baxter International Inc. - Pfizer Inc. - 3M Health Care Ltd - Genzyme Corporation - Teleflex Incorporated - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/mk...ted_states
JNJ: 107.78 (+0.74), BAX: 70.14 (+0.08), PFE: 29.95 (+0.11), TFX: 114.12 (+1.25)
Teleflex Partnership with ASA Raises Funds for Lifebox Foundation at ANESTHESIOLOGY(TM) 2014 Annual Meeting
Business Wire - Mon Oct 20, 8:03AM CDT
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices for critical care and surgery, has announced that they have donated $20,000 to the Lifebox Foundation. The donation was the result of a Lifebox Challenge hosted by Teleflex during the ANESTHESIOLOGY(TM) 2014 Annual Meeting in October. Teleflex donated $20 for every meeting attendee who participated in the Lifebox photo challenge.
TFX: 114.12 (+1.25)
Teleflex to Present at 44th Annual Meeting of the International Continence Society (ICS)
Business Wire - Fri Oct 17, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care, urology and surgery, will showcase its comprehensive bladder management product lines and incontinence care products at the 44th Annual Meeting of the International Continence Society (ICS) in Rio de Janeiro, Brazil on October 20-24, 2014.
TFX: 114.12 (+1.25)
Teleflex Announces Third Quarter 2014 Earnings Conference Call Information
Business Wire - Wed Oct 15, 6:00AM CDT
Teleflex Incorporated (NYSE: TFX) announced today that financial results for the third quarter 2014 will be released before market open on Wednesday, October 29, 2014. An investor conference call will be held at 8:00 a.m. (ET) on Wednesday, October 29, 2014. The call can be accessed through a live audio webcast on the company's website, www.teleflex.com. An audio replay of the call will also be available on the website from October 29, 2014 at 12:00 p.m. (ET) to November 5, 2014 at 11:59 p.m. (ET) by calling 888-286-8010 (U.S./Canada) or 617-801-6888 (International), Passcode: 14097601.
TFX: 114.12 (+1.25)
Teleflex Unites its World-Class Arrow(R), Hudson RCI(R), LMA(R) and Rusch(R) Brands at ANESTHESIOLOGY(TM) 2014
Business Wire - Thu Oct 09, 8:01AM CDT
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will be featuring medical technology designed to improve patient outcomes and reduce healthcare costs at the ANESTHESIOLOGY(TM) 2014 annual meeting, October 11-15th in New Orleans.
TFX: 114.12 (+1.25)
After Yesterday's Rally of 2.25% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Oct 06, 5:28PM CDT
Teleflex (NYSE:TFX) traded in a range yesterday that spanned from a low of $107.05 to a high of $109.42. Yesterday, the shares gained 2.2%, which took the trading range above the 3-day high of $107.19 on volume of 332,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TFX: 114.12 (+1.25)
Teleflex Incorporated Announces Worldwide Voluntary Recall of Hudson RCI(R) Pediatric Anesthesia Breathing Circuits
Business Wire - Fri Oct 03, 8:00AM CDT
Teleflex Incorporated announced today that the U.S. Food and Drug Administration (FDA) has classified the voluntary medical device recall of Hudson RCI(R) Pediatric Anesthesia Breathing Circuits as a Class 1 recall. FDA defines Class I recalls as, "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death."
TFX: 114.12 (+1.25)
Teleflex Up on Catheter Expansion Plans in Czech Republic - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Sep 30, 2:00PM CDT
Teleflex (TFX) rolled out its restructuring plan in April this year in order to reduce costs and streamline manufacturing operations.
ATEC: 1.52 (-0.05), TFX: 114.12 (+1.25), ERB: 3.08 (unch), HOLX: 26.19 (+0.27)
Global Home Healthcare Market 2014 - 2020: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices & Mobility Assist Devices and Medical Supplies
M2 - Tue Sep 30, 5:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/thxb6j/global_home) has announced the addition of the "Global Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. The global home healthcare market is estimated to be USD 176,107.9 million in 2013 and is expected to reach USD 303,605.9 million by 2020, growing at a CAGR of 8.1% from 2014 to 2020 Increasing sedentary lifestyle and aging population globally would surge the demand of home healthcare devices and services market. However, accuracy and limited geographic presence of service providers are some of the factors that restrict the growth of this market. For example, home healthcare service providers like The Linde Group and Gentiva Health Services, Inc. has limited market geographic presence in economies like Asia-Pacific, Russia and Latin America. The market of global home healthcare market is categorized as device types and services. Home healthcare devices market is segmented as diagnostics and monitoring home healthcare devices, therapeutics home healthcare devices, mobility assist devices and medical supplies. The market for diagnostics and monitoring devices segment accounted for the largest share owing to rising prevalence of chronic diseases coupled with increasing healthcare awareness. However, therapeutics home healthcare devices segment is expected to grow at the highest CAGR of over 10% from 2014 to 2020. Introduction of advanced and easy to use therapeutics home healthcare devices will help this segment to record highest CAGR. Services segment in the global home healthcare market accounted for the largest share in 2013. This dominance was majorly due to the presence of large number of home healthcare service providers and strong acquisition strategies of these healthcare service providers. The Global home healthcare market is segmented as follows: Global Home Healthcare Market, by Device Types Diagnostics and Monitoring Home Devices - Blood Glucose Monitors - Blood Pressure Monitors - Heart Rate Monitors - Temperature Monitors - Sleep Apnea Monitors - Coagulation Monitors - Pregnancy Test Kits - Pulse Oximeters - Pedometers Therapeutics Home Healthcare Devices - Insulin Delivery Devices - Nebulizers - Ventilator and CPAP Devices - IV Equipments - Dialysis Equipment Home Mobility Assist Devices - Wheelchairs - Cranes and Crutches - Other Home Mobility Assist Devices Medical Supplies Global Home Healthcare Market, by Services - Rehabilitation Services - Telehealth and Telemedicine Services - Infusion Therapy Services - Respiratory Therapy Services - Unskilled Home Healthcare Services Companies Mentioned - 3M Healthcare - Abbott Laboratories - Bayer AG - Becton, Dickinson and Company - Cardinal Health - F. Hoffmann-La Roche Ltd. - GE Healthcare - Gentiva Health Services, Inc. - Invacare Corporation - Johnson & Johnson Services, Inc. - Medtronic, Inc. - Omron Healthcare, Inc. - Philips Healthcare - Praxair Technologies, Inc. - ResMed, Inc. - Sunrise Medical LLC - Teleflex Incorporated - The Linde Group For more information visit http://www.researchandmarkets.com/research/th...lobal_home
JNJ: 107.78 (+0.74), ABT: 43.59 (+0.10), MDT: 68.16 (+0.73), IVC: 15.71 (+0.01), RMD: 52.22 (+0.11), TFX: 114.12 (+1.25), GTIV: 19.70 (+0.06)
Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
ZMH: 111.24 (+1.96), WST: 51.25 (+1.07), BDX: 128.70 (+1.18), PHG: 27.94 (+0.46), MDT: 68.16 (+0.73), CAH: 78.48 (+0.29), KMB: 114.27 (+0.65), EW: 120.92 (+0.64), WMGIZ: 4.39 (-0.06), MSA: 57.47 (+1.91), COO: 163.90 (+0.24), BSX: 13.28 (+0.10), ISRG: 495.80 (+5.80), JNJ: 107.78 (+0.74), PLL: 91.42 (+0.50), IVC: 15.71 (+0.01), STE: 61.80 (+0.96), BAX: 70.14 (+0.08), STJ: 64.17 (-0.11), TFX: 114.12 (+1.25), SYK: 87.53 (+0.49)
(0)
(0)Teleflex Inc. (TFX) Stock Research Links
Scroll down for more posts ▼